Monoclonal gammopathy and multiple myeloma in the elderly (Q39689347)

14 September 2017

1 reference

title

Monoclonal gammopathy and multiple myeloma in the elderly (English)

1 reference

14 September 2017

1 reference

Kyle RA

1

1 reference

14 September 2017

publication date

1 June 1987

1 reference

Best Practice and Research: Clinical Haematology

14 September 2017

published in

1 reference

14 September 2017

volume

1

1 reference

14 September 2017

issue

2

1 reference

14 September 2017

page(s)

533-557

1 reference

Monoclonal Gammopathy in Lymphoma

14 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2887%2980012-4

7 January 2021

Chemotherapy for multiple myeloma

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2887%2980012-4

7 January 2021

High-dose glucocorticoid treatment of resistant myeloma

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2887%2980012-4

7 January 2021

A 20-year follow-up study of 64 subjects with M-components

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2887%2980012-4

7 January 2021

Frequency of pathological proteins (M-components) om 6,995 sera from an adult population.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2887%2980012-4

7 January 2021

Effective treatment of advanced multiple myeloma refractory to alkylating agents.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2887%2980012-4

7 January 2021

Prognostic factors and staging in multiple myeloma: a reappraisal

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2887%2980012-4

7 January 2021

Multiple myeloma and family history of cancer. A case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2887%2980012-4

7 January 2021

Proximal renal tubular function in myelomatosis: observations in the fourth Medical Research Council trial

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2887%2980012-4

7 January 2021

Evaluation of monoclonal gammopathies in the "well" elderly

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2887%2980012-4

7 January 2021

Radiation-induced myelomatosis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2887%2980012-4

7 January 2021

The prognostic value of serum beta 2 microglobulin compared with other presentation features in myelomatosis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2887%2980012-4

7 January 2021

MRI in the detection of malignant infiltration of bone marrow

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2887%2980012-4

7 January 2021

Polyneuropathy with monoclonal gammopathy: Studies of 11 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2887%2980012-4

7 January 2021

In vitro myotrophic effect of serum kappa chain immunoglobulins from a patient with kappa light chain myeloma and muscular hypertrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2887%2980012-4

7 January 2021

A clinical staging system for multiple myeloma correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2887%2980012-4

7 January 2021

Relation of osteoclast activating factor production to extent of bone disease in multiple myeloma

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2887%2980012-4

7 January 2021

Improved survival duration with combination chemotherapy induction for multiple myeloma: a Southwest Oncology Group Study

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2887%2980012-4

7 January 2021

Necrobiotic xanthogranuloma with paraproteinemia. A review of 22 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2887%2980012-4

7 January 2021

Bone marrow transplantation in three patients with multiple myeloma

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2887%2980012-4

7 January 2021

Acquired C1 Esterase Inhibitor Deficiency and Angioedema

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2887%2980012-4

7 January 2021

Successful treatment of meningeal myeloma with combination of radiation therapy, chemotherapy, and intrathecal therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2887%2980012-4

7 January 2021

Malignant plasmacytic ascites. A report of two cases and a review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2887%2980012-4

7 January 2021

Melphalan resistance in myeloma

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2887%2980012-4

7 January 2021

Monoclonal gammopathy in chronic active hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2887%2980012-4

7 January 2021

Paraproteinaemia plus osteolytic lesions in typical hairy-cell leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2887%2980012-4

7 January 2021

Multiple myeloma in a pair of monozygotic twins: the first reported case

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2887%2980012-4

7 January 2021

Rapidly progressive glomerulonephritis and monoclonal gammopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2887%2980012-4

7 January 2021

Prevalence of monoclonal protein in peripheral neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2887%2980012-4

7 January 2021

Polymyositis associated with monoclonal gammopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2887%2980012-4

7 January 2021

Smoldering multiple myeloma

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2887%2980012-4

7 January 2021

The clinical aspects of biclonal gammopathies. Review of 57 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2887%2980012-4

7 January 2021

Plasma-Cell Dyscrasia and Peripheral Neuropathy with a Monoclonal Antibody to Peripheral-Nerve Myelin

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2887%2980012-4

7 January 2021

Pattern of reactivity of IgM from the sera of eight patients with IgM monoclonal gammopathy and neuropathy with components of neural tissues: evidence for interaction with more than one epitope

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2887%2980012-4

7 January 2021

Familial myeloma. Report of eight families and a study of serum proteins in their relatives

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2887%2980012-4

7 January 2021

Fanconi syndrome in adults. A manifestation of a latent form of myeloma

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2887%2980012-4

7 January 2021

Monoclonal gammopathies in adult T-cell leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2887%2980012-4

7 January 2021

Thirty cases of monoclonal immunoglobulin disorders other than myeloma or macroglobulinemia. A classification of diseases associated with the production of monoclonal-type immunoglobulins

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2887%2980012-4

7 January 2021

Monoclonal gammopathy in human neoplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2887%2980012-4

7 January 2021

Diagnostic value of the concentration of M-component in initial classification of monoclonal gammopathy.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2887%2980012-4

7 January 2021

Primary hyperparathyroidism and monoclonal gammopathy of undetermined significance

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2887%2980012-4

7 January 2021

Monoclonal proteins in chronic lymphocytic leukemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2887%2980012-4

7 January 2021

Monoclonal hypergammaglobulinemia without malignant transformation in angioimmunoblastic lymphadenopathy with dysproteinemia

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2887%2980012-4

7 January 2021

Neuropathy and motor neuron syndromes associated with plasma cell disease

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2887%2980012-4

7 January 2021

Influence of treatment and response status on infection risk in multiple myeloma

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2887%2980012-4

7 January 2021

Monoclonal gammapathies in patients undergoing immunosuppressive treatment after renal transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2887%2980012-4

7 January 2021

Monoclonal gammopathies in the adult population of Finistère, France

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2887%2980012-4

7 January 2021

Alternating combination chemotherapy and levamisole improves survival in multiple myeloma: a Southwest Oncology Group Study

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2887%2980012-4

7 January 2021

Changing patterns of infections in patients with multiple myeloma

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2887%2980012-4

7 January 2021

Motor neuron disease and plasma cell dyscrasia

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2887%2980012-4

7 January 2021

Publication bias: the case for an international registry of clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2887%2980012-4

7 January 2021

Monoclonal gammopathies in Japanese patients with Sjögren's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2887%2980012-4

7 January 2021

The frequency of M-components in sera of patients with solid malignant neoplasms

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2887%2980012-4

7 January 2021

Light chain nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2887%2980012-4

7 January 2021

10.1016/S0950-3536(87)80012-4

Identifiers

DOI

1 reference

14 September 2017

1 reference